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Abstract. Herpes simplex virus (HSV), cytomegalovirus 
(CMV) and Epstein-Barr virus (EBV) have been recognized 
as pathogenic agents of intraocular inflammatory conditions. 
The ability of the Polymerase Chain Reaction (PCR) 
technique to amplify HSV, CMV and EBV DNA from 
aqueous specimens makes this technique a valuable 
diagnostic tool for the detection of these viral pathogens in 
patients with ophthalmic lesions. We used PCR for the 
amplification of a 476 bp long sequence from the pol 1 gene 
of HSV genome, a 435 bp region of the immediate early-1 
(IE-1) gene of CMV and a 375 bp sequence from the EcoRI Β 
fragment of EBV genome. We examined 22 aqueous humour 
specimens from patients with uveitis and retinitis, 
inflammatory eye diseases, diagnosed clinically. We found 
HSV in 4 (18.2%), CMV in 6 (27.3%) and EBV in 1 (4.5%) 
out of the 22 examined patients. None of the 22 examined 
samples was found to be infected with more than one of the 
examined viral pathogens. These data confirm the 
implications of the members of Herpesvirus family in 
inflammatory inner eye diseases and the importance of PCR 
technique as a diagnostic tool in clinical virology. 
Introduction 
Intraocular inflammation caused by viral infection is one of 
the major known types of endogenous inflammatory eye 
diseases. Herpesviruses are common pathogens of retinitis in 
both immunosuppressed and immunocompromised patients 
(1). In particular, cytomegalovirus retinitis has been reported 
as the initial manifestation of the acquired immune deficiency 
syndrome (AIDS) (2,3). Cell culture of intraocular specimens 
testing for cytopathic effect (CPE) is the standard method for 
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making a specific virologie diagnosis of inflammatory 
intraocular disease. However, it appears to be particularly 
difficult when only a very small quantity of intraocular fluid 
is available (4). Moreover, cell culture is both expensive and 
time-consuming. Recently, molecular biology techniques 
have allowed in vitro amplification of specific nucleic acid 
sequences by PCR. The use of PCR for the detection of HSV, 
CMV and EBV DNA (5-7) and its specificity and sensitivity 
for the detection of viral genomes as well as other medical 
applications have been reported (8-10). 
In this study, we employed PCR to detect HSV, CMV 
and EBV DNA in aqueous humour from 22 patients with 
clinically diagnosed uveitis or retinitis. 
Materials and methods 
DNA extraction. NaOH was added to final concentration 0.1 Ν 
and samples were boiled for 5 min. Samples were extracted 
once with phenol and once with phenol/chloroform. DNA 
was precipitated with the addition of 20 μΐ 5 M NaCl and 1 ml 
ethanol. DNA was recovered by centrifugation at 13,000 rpm 
for 15 min at 4°C, washed once with 70% ethanol and 
resuspended in 50 μΐ of double-distilled water. 
Control DNA. The positive control used for HSV was DNA 
extracted from the aqueous humour from a patient with 
diagnosed herpetic uveitis, for CMV DNA extracted from the 
CMV plasmid pRR 47 and for EBV DNA extracted from 
peripheral blood leucocytes from a patient with infectious 
mononucleosis. 
Oligonucleotides and PCR amplification. HSV: A set of 
primers, termed HSV-a and HSV-b were used which have 
been previously described (13) to amplify a 476 bp long 
sequence from the DNA polymerase gene of both HSV I and 
HSV II. 
500 ng DNA of each sample were amplified in a volume 
of 100 μΐ containing 200 μπι of dNTPs, 75 pmoles of each 
primer, 75 mM Tris-HCl (pH 8.4), 200 mM (NH 4 ) 2 S0 4 , 
0.01% (w/v) Tween 20, 2.5 mM MgCl2 and 2.5 units Taq 
polymerase (Advanced Biotechnologies). Amplification was 
performed in a thermal cycler (Perkin Elmer Cetus) using the 
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Table I. Oligonucleotide primer sequences for the detection of HSV, CMV and EBV by the PCR technique. 
Virus Oligonucleotide primers Position Amplified region Amplified 
PCR product (bp) 
HSV 5'CAGTACGGCCCCGAGTTCGTGA 3' 5921-5942 
5'GTAGATGGTGCGGGTGATGTT 3' 6367-6387 pol 476 
CMV 5'CCAAGCGGCCTCTGATAACCAAGCC 3' 731-755 
5'CAGCACCATCCTCCTCTTCCTCTGG 3' 1150-1165 IE-1 435 
EBV 5'GTGTGCGTCGTGCCGGGGCAGCCAC 3' 102669-102694 
5'ACCTGGGAGGGCCATCGCAAGCTCC 3' 103019-103044 EcoRI Β 375 
following conditions: denaturation at 94°C for 60 sec, 
annealing at 64°C for 30 sec and extension at 72°C for 50 
sec, increasing the extension time by 1 sec per cycle. 
Samples were subjected to 40 cycles of amplification. 
CMV: A pair of primers, termed MIE-4 and MIE-5, 
which have been previously described (11) were used to 
amplify a 435 bp long sequence from the immediate early-1 
gene of HCMV. The primers along with the HCMV IE-1 
sequence have been described previously (12). 
500 ng DNA of each sample was amplified in a volume 
of 100 μΐ containing 200 μπι of dNTPs, 50 pmoles of each 
primer, 75 mM Tris-HCl (pH 8.4), 200 mM (NH 4 ) 2 S0 4 , 
0.01% (w/v) Tween 20, 2.5 mM MgCl2 and 2.5 units Taq 
polymerase. Amplification was performed in a thermal cycler 
using the following conditions: denaturation at 94°C for 50 
sec, annealing at 62°C for 30 sec and extension at 72°C for 
50 sec, increasing the extension time by 1 sec per cycle. 
Samples were subjected to 40 cycles of amplification. 
EBV: A set of primers specific for the amplification of a 
375 bp sequence from the EcoRI Β fragment of EBV, termed 
EBV-1 and EBV-2, were used (14,15). The primers along 
with the EBV genome have been described previously (16). 
PCR was performed with 500 ng genomic DNA in 100 μΐ 
of the reaction containing 10 mM Tris HCl at pH 8.3, 50 mM 
KCl, 1.5 mM MgCl2, 0.001% gelatin, 200 mM dNTPs, 40 
pmoles of each primer and 2.5 U of Taq polymerase. Prior to 
the addition of Taq polymerase, samples were heated at 98°C 
for 5 min. Amplification was performed in a Perkin Elmer 
Cetus Thermal Cycler with the following parameters: 
denaturation at 95 °C for 1 min, annealing and extension at 
72°C for 1 min, for 35 cycles. 
The sequences of the oligonucleotide primers used, their 
location in the viral genomes and the amplified regions are 
shown in Table I. 
Twenty μ] of the amplification products were analysed on 
a 2% agarose gel and visualized under UV illumination after 
staining with ethidium bromide. 
Endonuclease cleavage for the differentiation of HSV! and 
HSV2. Ten to twenty μΐ of the amplification products of the 
samples which showed the 476 bp band were further 
cleavaged using 80 units of the restriction endonuclease 
Avail (New England Biolabs). Samples were digested O/N at 
37°C. The conditions followed for digestion were those 
recommended by the supplier. There is a single Avail site in 
the amplified sequence of HSV2 that cleaves the 476 bp 
product into 87 and 389 bp fragments. An additional Avail 
site is present in the amplified fragment of HSV1, resulting 
in fragments of 87, 183 and 206 bp. This allows differentiation 
of HSV1 and HSV2 with a single restriction enzyme 
cleavage. 
Digestion products were electrophoresed through a 2% 
agarose gel and photographed on a UV transilluminator after 
staining with ethidium bromide. 
Endonuclease cleavage for the reconfirmation of the 
specificity of EBV DNA amplification. Thirty μΐ of the 
amplified PCR product showing the 375 bp band was 
digested with 100 U from the restriction endonuclease 
Hindlll (New England Biolabs). Samples were digested O/N 
at 37°C. The conditions followed for digestion were those 
recommended by the supplier. There is a single Hindlll site 
in the amplified sequence of EBV that cleaves the 375 bp 
product into 214 and 161 bp fragments. 
Digestion products were electrophoresed through a 2% 
agarose gel and photographed on a UV transilluminator after 
staining with ethidium bromide. 
Results 
We examined 22 aqueous humour samples from patients 
with active, clinically diagnosed retinitis (N=7) or uveitis 
(N=15). Our results are summarised in Table IL HSV DNA 
was detected in 4 (18.2%) (Fig. 1), CMV DNA in 6 (27.3%) 
(Fig. 2) and EBV DNA in 1 (4.5%) (Fig. 3) out of the 22 
examined samples. HSV DNA was detected in 1 and CMV 
DNA in 3 out of the 7 examined patients with retinitis. EBV 
DNA was not detected in any of the examined samples from 
patients with retinitis. HSV DNA was detected in 3, CMV 
DNA in 3 and EBV DNA in 1 out of the 15 examined 
patients with uveitis. None of the 22 examined patients was 
found to be co-infected with HSV, CMV or EBV. Samples 
which were found positive for HSV were followed by 
endonuclease cleavage using the restriction endonuclease 
Avail for the differentiation between the two types of HSV. 
All the samples were found to be HSV 1 (Fig. 4). Ocular 
infection caused by EBV is not very common. Thus, the 
restriction endonuclease Hindlll was used to reconfirm the 
specificity of the amplification of EBV DNA. There is a 
unique Hindlll cleavage site in the amplified fragment of 
EBV whereas the amplified PCR product is digested in two 
fragments of 214bp and 161bp (Fig. 5). 
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Table II. Summary of results on the detection of HSV, CMV and EBV in patients with inflammatory eye diseases. 
Study cases No. of patients HSV positive CMV positive EBV positive 
Retinitis 7 1 3 0 
Uveitis 15 3 3 1 
Total 22 4(18.2%) 6(27.3%) 1(4.5%) 
Figure 1. Detection of HSV DNA by PCR. Amplification products were 
electrophoresed through a 2% agarose gel. Lane 1: pUC18/HaeIII molecular 
marker, lane 2: negative control, lane 3: positive control, lanes 4, 7: positive 
samples, lanes 5, 6, 8: negative samples. 
Figure 2. Detection of CMV DNA by PCR. Amplification products were 
electrophoresed through a 2% agarose gel. Lane 1: pUC18/HaeIII molecular 
marker, lane 2: negative control, lane 3: positive control, lanes 4, 8: positive 
samples, lanes 6, 8: negative samples. 
Figure 3. Detection of EBV DNA by PCR. Amplification products were 
electrophoresed through a 2% agarose gel. Lane 1: pUC18/HaeIH molecular 
marker, lane 2: negative control, lane 3: positive control, lanes 4, 6, 7, 8: 
negative samples, lane 5: positive sample. 
Discussion 
Intraocular inflammation caused by viral infection represents 
one of the major known types of endogenous inflammatory 
eye diseases (17). Infections caused by herpesviruses are very 
common in immunosuppressed and immunocompromised 
patients. Moreover, ocular diseases in these specific 
populations are strongly associated with infections caused by 
Figure 4. Endonuclease cleavage for the differentiation of HSV type. 
Digestion products were electrophoresed through a 2% agarose gel. Lane 1 : 
pUC18/HaeIII molecular marker, lane 2: undigested PCR product, lane 3: 
HSV 1 positive control, lanes 4, 5, 6: HSV 1 samples. 
Figure 5. Endonuclease cleavage for the reconfirmation of the specificity of 
EBV DNA amplification. Digestion products were electrophoresed through 
a 2% agarose gel. Lane 1: pUC18/HaeIII molecular marker, lane 2: 
undigested PCR product, lane 3: EBV positive control, lane 4: EBV positive 
sample. 
members of the herpesvirus family (18,19). However, 
establishment of the diagnosis of ocular disease due to viral 
infection is usually difficult. Although a clinical diagnosis of 
viral ocular infection is most frequently made, based on the 
typical appearance of chorioretinal lesions, in patients with 
atypical features, it may be difficult to differentiate, based on 
clinical findings alone, between viral infections due to herpes 
group viruses or other nonviral pathogens. As the 
recommended antiviral treatments differ for the various 
herpes group viruses, optimal management and treatment 
require a rapid as well as specific laboratory diagnosis for 
establishing appropriate antiviral therapy. Current laboratory 
techniques for the detection of herpesviruses in ophthalmic 
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lesions are based on serology and cell culture. However, both 
approaches have significant d isadvantages such as low 
specificity and sensitivity. Also, cost and time consumed 
must be considered. PCR has been proved to be accurate and 
very sensitive when applied for the detection of viral DNA in 
almost every type of clinical sample (20-24). 
In this study, we employed PCR to detect herpesvirus 
D N A in aqueous h u m o u r from pat ients with cl inical ly 
diagnosed retinitis, or uveitis. None of the 22 examined 
patients was immunosuppressed or immunocompromised at 
the time of examination. Presence of HSV, CMV and EBV 
DNA was consequently judged from the amplification of a 
476, 435 and 375 bp long sequences (Figs. 1-3). 
Samples which were found to be H S V positive were 
further checked for the differentiation of HSV type. All HSV 
positive samples were found to be HSV type 1. This result 
was based on the 206, 183 and 87 bp fragments after the 
endonuclease cleavage of HSV PCR products (Fig. 4). 
Our data suggest that HSV 1 and C M V may play an 
important role in ocular inflammatory diseases. Also, the use 
of the PCR technique for the direct detection of herpesvirus 
D N A in aqueous humour samples seems to be of major 
importance. PCR may be important in the laboratory for the 
detection of viral agents in the early stages of the inner eye 
infection offering the opportunity for prompt treatment, 
especially during the acute stage of the disease. 
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